- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Ferroptosis: a new hunter of hepatocellular carcinoma ; volume:10 ; number:1 ; day:13 ; month:3 ; year:2024 ; pages:1-16 ; date:12.2024
Cell death discovery ; 10, Heft 1 (13.3.2024), 1-16, 12.2024
- Urheber
-
Jiang, Yulang
Yu, Yongxin
Pan, Ziyang
Glandorff, Christian
Sun, Mingyu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41420-024-01863-1
- URN
-
urn:nbn:de:101:1-2405152124573.628330143130
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jiang, Yulang
- Yu, Yongxin
- Pan, Ziyang
- Glandorff, Christian
- Sun, Mingyu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cyclovirobuxine D inhibits hepatocellular carcinoma growth by inducing ferroptosis of hepatocellular carcinoma cells
Ferroptosis: insight into the treatment of hepatocellular carcinoma
Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma
A novel cholesterol metabolism-related ferroptosis pathway in hepatocellular carcinoma
Histidine phosphatase-ferroptosis crosstalk modulation for efficient hepatocellular carcinoma treatment
METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
Curcumin promotes ferroptosis in hepatocellular carcinoma via upregulation of ACSL4
Redox modulation and induction of ferroptosis as a new therapeutic strategy in hepatocellular carcinoma
Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma
PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma
Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion
LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination
Cyclovirobuxine D inhibits hepatocellular carcinoma growth by inducing ferroptosis of hepatocellular carcinoma cells
Ferroptosis: insight into the treatment of hepatocellular carcinoma
Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma
A novel cholesterol metabolism-related ferroptosis pathway in hepatocellular carcinoma
Histidine phosphatase-ferroptosis crosstalk modulation for efficient hepatocellular carcinoma treatment
METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
Curcumin promotes ferroptosis in hepatocellular carcinoma via upregulation of ACSL4
Redox modulation and induction of ferroptosis as a new therapeutic strategy in hepatocellular carcinoma
Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma
PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma
Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion
LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination
Cyclovirobuxine D inhibits hepatocellular carcinoma growth by inducing ferroptosis of hepatocellular carcinoma cells
Ferroptosis: insight into the treatment of hepatocellular carcinoma
Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma
A novel cholesterol metabolism-related ferroptosis pathway in hepatocellular carcinoma
Histidine phosphatase-ferroptosis crosstalk modulation for efficient hepatocellular carcinoma treatment
METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
Curcumin promotes ferroptosis in hepatocellular carcinoma via upregulation of ACSL4
Redox modulation and induction of ferroptosis as a new therapeutic strategy in hepatocellular carcinoma
Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma
PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma
Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion